JAMEY RENNINGER: Open Payments
NPI 1063196947 · DOUGLASSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 31 payments from 12 companies in 2025. Trend: 2023 $317 · 2024 $1,081 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $159 |
| Lilly USA, LLC | 5 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| PFIZER INC. | 2 | $47 |
| Exact Sciences Corporation | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: MOUNJARO, XIFAXAN, Wegovy, SHINGRIX, JARDIANCE, Cologuard Collection Kit, NURTEC ODT, BREZTRI.
Industry payments across PA — which companies pay providers there.
